The purpose of the report is to illustrate the state of the market of Tuberculosis Diagnostics, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.
Browse here for full report: https://www.credenceresearch.com/report/tuberculosis-diagnostics-market
According to World Health organization in 2015 the MDR-TB reported cases were 480,000. The tuberculosis diagnostics kit has undergone tremendous technological advancement to give better accuracy, quick results, and available at low cost. For the purpose of this study, the global tuberculosis diagnostics market is segmented into test types which includes radiographic methods, laboratory methods, nucleic acid testing, phage assay, cytokine detection test, detection of drug resistance, and Mantoux test. In base year 2016, laboratory methods are leading the types segment due to rising prevalence of tuberculosis, easy collection of specimen sample and available at low cost. Nucleic acid testing, cytokine detection test segment is anticipated to register faster growth in the test types segment throughout the forecast period 2017-2025, as it is providing greater accuracy and requires less incubation period for the interpretation of the results. In 2016 Asia Pacific region dominated the tuberculosis diagnostics market due to factors such as large patient pool suffering with tuberculosis, government and non-government initiatives to eradicate tuberculosis and high disposable income in these regions. North America will register fastest growth throughout the forecast period 2017-2025, mainly due to factors such as rising public awareness regarding contagious diseases, advanced healthcare infrastructure and affordable reimbursement policies.
The tuberculosis diagnostics market is technologically driven and includes major players such as Thermo Fisher Scientific Corporation, Alere Inc., Abbott Laboratories, and Becton Dickinson and Company, among others are few market leaders in tuberculosis diagnostics market and compete to augment their foothold in the market.
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Tuberculosis Diagnostics Market Portraiture
2.2 Global Tuberculosis Diagnostics Market, by Test Type 2016 Vs 2025 (US$ Mn)
2.3 Global Tuberculosis Diagnostics Market, by Geography, 2016 (Value %)
Chapter 3 Global Tuberculosis Diagnostics Market: Market Dynamics and Future Outlook
3.2 Market Drivers
3.2.1 Rising prevalence of Tuberculosis
3.2.2 For a full, detailed list, browse our report
3.3 Market Restraints
3.3.1 Costly diagnosis and lack of skilled labor to perform accurate diagnosis will hinder the growth of tuberculosis diagnostic market
3.3.2 For a full, detailed list, browse our report
3.4 Market Opportunities
3.4.1 Increasing number of patients reported with MDR-TB and hospital acquired infection
3.4.2 For a full, detailed list, browse our report
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Global Tuberculosis Diagnostics Market, by Key Players
Chapter 4 Global Tuberculosis Diagnostics Market, by Test Type, 2015-2025 (US$ Mn)
4.2 Radiographic Methods
4.3 Laboratory Methods
4.3.1 Smear Microscopy
4.3.2 Culture Based Test
4.4 Nucleic Acid Testing
4.5 Phage Assay
4.6 Cytokine Detection Test
4.7 Detection of Drug Resistance
4.8 Mantoux Test
Chapter 5 Global Tuberculosis Diagnostics Market, by Geography, 2015-2025 (US$ Mn)
5.2 North America
5.2.1 North America Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.2.2 North America Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
5.3.1 Europe Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.3.2 Europe Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
18.104.22.168 Rest of Europe
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Diagnostics Market, by Test Type, 2015-2025 (US$ Mn)
5.4.2 Asia Pacific Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
22.214.171.124 Rest of Asia Pacific
5.5 Latin America
5.5.1 Latin America Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.5.2 Latin America Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
126.96.36.199 Rest of Latin America
5.6 Middle East and Africa
5.6.1 Middle East and Africa Tuberculosis Diagnostics Market,by Test Type, 2015-2025 (US$ Mn)
5.6.2 Middle East and Africa Tuberculosis Diagnostics Market,by Country, 2015-2025 (US$ Mn)
188.8.131.52 Rest of Middle East and Africa
Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Alere, Inc.
6.3 Becton Dickinson and Company
6.4 bioMérieux SA
6.5 Cepheid Inc.
6.6 Epistem plc
6.7 F. Hoffman La Roche AG
6.8 Hain Lifescience GmbH
6.9 Hologic Corporation
6.10 Thermo Fisher Scientific, Inc.
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Tuberculosis Diagnostics buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Tuberculosis Diagnostics contains:
Analysis and forecast of Tuberculosis Diagnostics market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Tuberculosis Diagnostics market;
Assessment and forecast of Tuberculosis Diagnostics market development;
Financial and business profiles of the leading companies in the Tuberculosis Diagnostics industry.
– Up to date working Tuberculosis Diagnostics data by major regions in the world, the forecast of planned capacity additions by 2026
– The annual breakdown of capital expenditure spending on proposed Tuberculosis Diagnostics for the period 2018 to 2026
– Planned Tuberculosis Diagnostics additions and capital expenditure spending by key countries and companies across the world
– Planned capital expenditure spending on new Tuberculosis Diagnostics projects by region, key countries, and companies
– Details of major planned Tuberculosis Diagnostics projects in the world up to 2026
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58571
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Credence Research Inc.
105 N 1st ST #429
Toll Free (US/CANADA): +1-800-361-8290